Enrico Cerrato to Stents
This is a "connection" page, showing publications Enrico Cerrato has written about Stents.
Connection Strength
0.398
-
Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry. Catheter Cardiovasc Interv. 2018 12 01; 92(7):1247-1255.
Score: 0.108
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Rev Esp Cardiol (Engl Ed). 2019 Apr; 72(4):298-304.
Score: 0.106
-
What is the optimal treatment for symptomatic patients with isolated coronary myocardial bridge? A systematic review and pooled analysis. J Cardiovasc Med (Hagerstown). 2017 Oct; 18(10):758-770.
Score: 0.101
-
Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study. Minerva Cardioangiol. 2019 Apr; 67(2):94-101.
Score: 0.028
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
Score: 0.028
-
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):536-542.
Score: 0.027